- Bee Vectoring (BEE) has announced higher U.S. grower sales commitments for 2022
- The company has increased YoY sales by 18 per cent just seven months into its fiscal year
- It is also in discussions with some of the largest berry growers along the U.S. Pacific coast
- Bee Vectoring Technologies offers biological pesticide alternatives using commercially grown bees
- Bee Vectoring (BEE) is unchanged trading at $0.215 per share
Bee Vectoring (BEE) has announced higher U.S. grower sales commitments for 2022.
The company has increased YoY sales by 18 per cent just seven months into its fiscal year. This includes unchanged YoY sales in Georgia, the company’s largest market last year, in spite of severe weather resulting in partial or complete crop losses for numerous growers.
These positive results are in the face of inflationary farming conditions, including a doubling in fertilizer prices over the last year, and prices for fuel and other essential chemical products increasing by up to 40 per cent.
The company is currently in discussions with some of the largest berry growers along the U.S. Pacific coast.
“Farmers are being squeezed harder than ever and they have had to make tough choices on which products to invest in to help their crops thrive this year,” said Ashish Malik, Bee Vectoring’s CEO.
“Already achieving year-over-year sales increases for BVT, with several months still to go, is a testament to the strength and efficacy of our natural precision agriculture system and proprietary Clonostachys rosea CR-7 biological fungicide,” he added.
Bee Vectoring Technologies is an agriculture technology company offering biological pesticide alternatives using commercially grown bees.
Bee Vectoring (BEE) is unchanged trading at $0.215 per share as of 10:54 am EST.